Neurofibromatosis type 2 French cohort analysis using a comprehensive NF2 molecular diagnostic strategy
Abstract
Neurofibromatosis type 2 (NF2) affects about one in 25,000 to 40,000 people. Most NF2 patients have private loss-of-function mutations scattered along the NF2 gene. Here, we present our NF2 investigation strategy.